HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul E Kinahan Selected Research

Therapeutics

3/2024Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials.
1/2024Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials.
1/2023Animal Models and Their Role in Imaging-Assisted Co-Clinical Trials.
9/2022Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?
1/202118F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study.
1/2020The QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy.
1/2019Voxel Forecast for Precision Oncology: Predicting Spatially Variant and Multiscale Cancer Therapy Response on Longitudinal Quantitative Molecular Imaging.
1/2018Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.
10/2017Simulation study of quantitative precision of the PET/X dedicated breast PET scanner.
1/2017A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul E Kinahan Research Topics

Disease

30Neoplasms (Cancer)
04/2024 - 10/2004
9Breast Neoplasms (Breast Cancer)
03/2024 - 06/2007
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022 - 07/2017
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2020 - 10/2004
2Neoplasm Metastasis (Metastasis)
03/2024 - 01/2024
2Lung Neoplasms (Lung Cancer)
11/2019 - 08/2012
2Hepatocellular Carcinoma (Hepatoma)
12/2016 - 05/2015
2Lung Diseases (Lung Disease)
10/2014 - 12/2010
1Alzheimer Disease (Alzheimer's Disease)
01/2023
1Chronic Obstructive Pulmonary Disease (COPD)
09/2022
1Pneumonia (Pneumonitis)
09/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2022
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2018
1AIDS-Related Complex (ARC)
05/2015
1Pathologic Complete Response
01/2013
1Glioma (Gliomas)
03/2012
1Hypoxia (Hypoxemia)
03/2012
1Brain Neoplasms (Brain Tumor)
07/2010
1Pheochromocytoma
02/2006
1Colonic Neoplasms (Colon Cancer)
10/2004
1Colorectal Neoplasms (Colorectal Cancer)
10/2004

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
04/2024 - 12/2009
7Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2024 - 02/2006
4Glucose (Dextrose)FDA LinkGeneric
03/2024 - 12/2010
1AutoantibodiesIBA
06/2023
1AntigensIBA
06/2023
1Proteins (Proteins, Gene)FDA Link
06/2023
1Polysaccharides (Glycans)IBA
06/2023
1Amyloid (Amyloid Fibrils)IBA
01/2023
1Immune Checkpoint InhibitorsIBA
09/2022
1B7-H1 AntigenIBA
03/2022
1PlatinumIBA
03/2022
1Estrogen ReceptorsIBA
01/2021
1Aromatase InhibitorsIBA
01/2021
1SulfurIBA
12/2016
1Colloids (Colloid)IBA
12/2016
1fluoromisonidazoleIBA
03/2012
1A 17 (A-17)IBA
05/2011
1antineoplaston A10 (A 10)IBA
05/2011
13-Iodobenzylguanidine (Iobenguane)IBA
02/2006
1UracilIBA
10/2004
1DNA (Deoxyribonucleic Acid)IBA
10/2004
1Fluorine-18IBA
10/2004
1ProdrugsIBA
10/2004
1Thymidylate SynthaseIBA
10/2004
1ThymineIBA
10/2004
1Fluorouracil (Carac)FDA LinkGeneric
10/2004
1clevudineIBA
10/2004
1Therapeutic UsesIBA
10/2004

Therapy/Procedure

26Therapeutics
03/2024 - 08/2006
8Radiotherapy
11/2021 - 11/2006
2Precision Medicine
04/2024 - 11/2023
2Drug Therapy (Chemotherapy)
03/2022 - 06/2007
2Chemoradiotherapy
11/2021 - 01/2019
2Neoadjuvant Therapy
02/2014 - 01/2013
1Aftercare (After-Treatment)
09/2022
1Immunotherapy
09/2022
1Brachytherapy
01/2018
1Investigational Therapies (Experimental Therapy)
12/2016
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
11/2006
1Adrenalectomy
02/2006